Incyte | INCY - Market Capitalization

Stock Price
95.31
Daily Change
-2.32 -2.38%
Monthly
-0.01%
Yearly
50.54%
Q2 Forecast
93.39

Incyte reported $21.45B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Agenus USD 107M 16M Dec/2025
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Exelixis USD 14.34B 3.44B May/2026
Gilead Sciences USD 167.39B 5.6B May/2026
Incyte USD 21.73B 3B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
MacroGenics USD 102M 4M Dec/2025
Merck USD 297.1B 35.84B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 147.4B 6.42B May/2026
PTC Therapeutics USD 4.94B 698M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026